Efficacy and safety of co administered once weekly cagrilintide 24 mg with once weekly semaglutide 24 mg in type 2 diabetes: a multicentre, randomised, double blind, active controlled, phase 2 trial The Lancet PDF] Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 24 mg for weight management: a randomised, controlled, phase 1b trial. Semantic Scholar What is cagrilintide (glucagon like peptide 1 receptor agonist) used for in the management of type 2 diabetes and obesity? Development of Cagrilintide, a Long Acting Amylin Analogue Journal of Medicinal Chemistry